Abstract
Background: Little is known about breast milk as a vehicle for tolerance development or sensitization to peanuts very early in life. Thus, well-characterized and highly sensitive detection systems for the reliable determination of peanut allergens in breast milk are mandatory. Methods: For the quantification of the marker allergens Ara h 2 and Ara h 6 in the low nanogram per milliliter range in breast milk samples of a German cohort, sensitive and highly specific sandwich ELISAs were optimized and validated. Results: The Ara h 2 ELISA revealed a limit of detection (LOD) of 1.3 ng Ara h 2/mL and a quantification range of 2.3-250 ng/mL, the Ara h 6 ELISA showed an LOD of 0.7 ng/mL and a working range of 1.1-14.4 ng/mL. The assays showed no relevant cross-reactivity against other potentially cross-reactive legume, seed, and tree nut extracts (<0.01%, except for Ara h 1 in the Ara h 2 ELISA <0.1%). Ara h 2 was detectable in breast milk samples from 14/40 (35%) of the participants in concentrations from 2.3 to 184 ng/mL, Ara h 6 appeared in 9/40 (22.5%) of the lactating mothers between 1.1 and 9.7 ng/mL, and 1 highly positive sample with 79 ng/mL. Both allergens appeared at the same time points, but Ara h 6 in lower concentrations than Ara h 2. Conclusions: Sensitive and specific diagnostic tools for the determination of Ara h 2 and Ara h 6 in human breast milk were established. The kinetics of secreted Ara h 2 and Ara h 6 seem to be similar but with a difference in concentration. Follow-up investigations on their tolerogenic or sensitizing properties in breast milk become now accessible.
Journal Section:
Editor's choice
References
1.
Kilshaw PJ, Cant AJ: The passage of maternal dietary proteins into human breast milk. Int Arch Allergy Appl Immunol 1984;75:8-15.
[PubMed]
2.
Fukushima Y, Kawata Y; Onda T, Kitagawa M: Consumption of cow´s milk and egg by lactating women and the presence of beta-lactoglobulin and ovalbumin in breast milk. Am J Clin Nutr 1997;65:30-31.
[PubMed]
3.
Cant A, Marsden RA, Kilshaw PJ: Egg and cow's milk hypersensitivity in exclusively breast fed infants with eczema, and detection of egg protein in breast milk. Br Med J 1985;291:932-935.
[PubMed]
4.
Troncone R, Scarcella A, Donatiello A, Cannataro P, Tarabuso A, Auricchio S: Passage of gliadin into human breast milk. Acta Paediatr Scand 1987;76:453-456.
[PubMed]
5.
Chirdo FG, Rumbo M, Añón MC, Fossati CA: Presence of high levels of non-degraded gliadin in breast milk from healthy mothers. Scand J Gastroenterol 1998;33:1186-1192.
[PubMed]
6.
Worm M, Eckermann O, Dölle S, Aberer W, Beyer K, Hawranek T, Hompes S, Koehli A, Mahler V, Nemat K: Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland. Dtsch Ärztebl Int 2014;111:367.
[PubMed]
7.
Ewan PW: Clinical study of peanut and nut allergy in 62 consecutive patients: new features and associations. BMJ 1996;312:1074-1078.
[PubMed]
8.
Hourihane JO, Dean TP, Warner JO: Peanut allergy in relation to heredity, maternal diet, and other atopic diseases: results of a questionnaire survey, skin prick testing and food challenges. BMJ 1996;313:518-521.
[PubMed]
9.
Eller E, Bindslev-Jensen C: Clinical value of component-resolved diagnostics in peanut allergic patients. Allergy 2013;68:190-194.
[PubMed]
10.
Klemans RJ, Otte D, Knol M, Knol E, Meijer Y, Gmelig-Meyling FH, Bruijnzeel-Koomen CA, Knulst AC. Pasmans SG: The diagnostic value of specific IgE to Ara h 2 to predict peanut allergy in children is comparable to a validated and updated diagnostic prediction model. J Allergy Clin Immunol 2013;131:157-163.
[PubMed]
11.
Dang TD, Tang M, Choo S, Licciardi PV, Koplin JJ, Martin PE, Tan T, Gurrin LC, Ponsonby AL, Tey D, Robinson M, Dharmage SC, Allen KJ: Increasing the accuracy of peanut allergy diagnosis by using Ara h 2. J Allergy Clin Immunol 2012;129:1056-1063.
[PubMed]
12.
Martinet J, Couderc L, Renosi F, Bobée V, Marguet C, Boyer O: Diagnostic value of antigen-specific immunoglobulin E immunoassays against Ara h 2 and Ara h 8 peanut components in child food allergy. Int Arch Allergy Immunol 2016;169:216-222.
[PubMed]
13.
Suhr M, Wicklein D, Lepp U, Becker WM: Isolation and characterization of natural Ara h 6: evidence for a further peanut allergen with putative clinical relevance based on resistance to pepsin digestion and heat. Mol Nutr Food Res 2004;48:390-399.
[PubMed]
14.
Ackerbauer D, Bublin M, Radauer C, Varga E-M, Hafner C, Ebner C, Szépfalusi Z, Fröschl R, Hoffmann-Sommergruber K, Eiwegger T, Breiteneder H: Component-resolved IgE profiles in Austrian patients with a convincing history of peanut allergy. Int Arch Allergy Immunol 2015;166:13-24.
[PubMed]
15.
Koppelman SJ, de Jong GAH, Laaper-Ertmann M, Peeters KABM, Knulst AC, Hefle SL, Knol EF: Purification and immunoglobulin E-binding properties of peanut allergen Ara h 6: evidence for cross-reactivity with Ara h 2. Clin Exp Allergy 2005;35:490-497.
[PubMed]
16.
Young MC: Taking the leap earlier: the timing of tolerance. Curr Opin Pediatr 2015;27:736-740.
[PubMed]
17.
Vadas P, Wai Y, Burks W, Perelman B: Detection of peanut allergens in breast milk of lactating women. JAMA 2001;285:1746-1748.
[PubMed]
18.
Bernard H, Ah-Leung S, Drumare MF, Feraudet-Tarisse C, Verhasselt V, Wal JM, Créminon C, Adel-Patient K: Peanut allergens are rapidly transferred in human breast milk and can prevent sensitization in mice. Allergy 2014;69:888-897.
[PubMed]
19.
Schocker F, Baumert J, Kull S, Petersen A, Becker WM, Jappe U: Prospective investigation on the transfer of Ara h 2, the most potent peanut allergen, in human breast milk of 32 volunteers. Pediatr Allergy Immunol 2016;27:348-355.
[PubMed]
20.
Gruber P, Suhr M, Frey A, Becker WM, Hofmann T: Development of an epitope-specific analytical tool for the major peanut allergen Ara h 2 using a high-density multiple-antigenic peptide strategy. Mol Nutr Food Res 2004;48:449-458.
[PubMed]
21.
Stanley JS, King N, Burks AW, Huang SK, Sampson H, Cockrell G, Bannon GA: Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch Biochem Biophys 1997;342:244-253.
[PubMed]
22.
Salonen EM, Vaheri A: Rapid solid-phase enzyme immunoassay for antibodies to viruses and other microbes: effects of polyethylene glycol. J Immunol Methods 1981;41:95-103.
[PubMed]
23.
British Standards Institution: Foodstuffs - Detection of Food Allergens by Immunological Methods − Part 1: General Considerations. London, BSI, 2009.
24.
British Standards Institution: Detection of Food Allergens: General Considerations and Validation of Methods. London, BSI, 2010.
25.
International Organization for Standardization: ISO 11843-5: Capability of Detection - Part 5: Methodology in the Linear and Non-Linear Calibration Cases. Geneva, ISO, 2008.
26.
Schocker F, Lüttkopf D, Müller U, Thomas P, Vieths S, Becker WM: IgE binding to unique hazelnut allergens: identification of non pollen-related and heat-stable hazelnut allergens eliciting severe allergic reactions. Eur J Nutr 2000;39:172-180.
[PubMed]
27.
Mueller GA, Gosavi RA, Pomés A, Wünschmann S, Moon AF, London RE, Pedersen LC: Ara h 2: crystalstructure and IgE binding distinguish two subpopulations of peanut allergic patients by epitope diversity. Allergy 2011;66:878-885.
[PubMed]
28.
Bublin M, Kostadinova M, Radauer C, Hafner C, Szépfalusi Z, Varga EM, Maleki SJ, Hoffmann-Sommergruber K, Breiteneder H: IgE cross-reactivity between the major peanut allergen Ara h 2 and the nonhomologous allergens Ara h 1 and Ara h 3. J Allergy Clin Immunol 2013;132:118-124.
[PubMed]
29.
Dooper MM, Plassen C, Holden L, Lindvik H, Faeste CK: Immunoglobulin E cross-reactivity between lupine conglutins and peanut allergens in serum of lupine-allergic individuals. J Investig Allergol Clin Immunol 2009;19:283-291.
[PubMed]
30.
Jayasena S, Smits M, Fiechter D, de Jong A, Nordlee J, Baumert J, Taylor SL, Pieters RH, Koppelman SJ: Comparison of six commercial ELISA kits for their specificity and sensitivity in detecting different major peanut allergens. J Agric Food Chem 2015;63:1849-1855.
[PubMed]
31.
Koppelman SJ, Hefle SL, Taylor SL, de Jong GAH: Digestion of peanut allergens Ara h 1, Ara h 2, Ara h 3, and Ara h 6: a comparative in vitro study and partial characterization of digestion-resistant peptides. Mol Nutr Food Res 2010;54:1711-1721.
[PubMed]
32.
Price DB, Ackland ML, Burks W, Knight MI, Suphioglu C: Peanut allergens alter intestinal barrier permeability and tight junction localisation in Caco-2 cell cultures. Cell Physiol Biochem 2014;33:1758-1777.
[PubMed]
33.
Price D, Ackland ML, Suphioglu C: Identifying epithelial endocytotic mechanisms of the peanut allergens Ara h 1 and Ara h 2. Int Arch Allergy Immunol 2017;172:106-115.
[PubMed]
34.
JanssenDuijghuijsen LM, Wichers HJ, van Norren K, Keijer J, Baumert JL, de Jong GA, Witkamp RF, Koppelman SJ: Detection of peanut allergen in human blood after consumption of peanuts is skewed by endogenous immunoglobulins. Immunol Methods 2017;440:52-57.
[PubMed]
35.
Hourihane JO, Kilburn SA, Nordlee JA, Hefle SL, Taylor SL, Warner JO: An evaluation of the sensitivity of subjects with peanut allergy to very low doses to peanut protein: a randomized, double-blind, placebo-controlled food challenge study. J Allergy Clin Immunol 1997;100:596-600.
[PubMed]
© 2017 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2017
You do not currently have access to this content.
